Robeco Institutional Asset Management B.V.
Position in EXEL — Exelixis, Inc.
CIK 1418773
ROTTERDAM, P7
Position in EXEL
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$56,032,451
+$742,910 QoQ
Shares Held
1,029,819
-20.1% QoQ
Ownership
0.416%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#45
of 751 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $992,672,242 across 15 Biotechnology names. EXEL ranks #5 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
460,602 | $287,203,771 | |
| 2 | INCY |
Incyte Corp
|
2,441,735 | $276,795,079 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
404,396 | $200,875,625 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
188,084 | $56,618,926 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
1,029,819 | $56,032,451 | |
| 6 | RPRX |
Royalty Pharma plc
|
911,586 | $51,112,627 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
117,612 | $28,340,963 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
408,215 | $23,358,062 |
All Filings in EXEL
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,032,451 | 1,029,819 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $55,289,541 | 1,289,101 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $56,509,624 | 1,289,291 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $40,484,118 | 980,245 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $40,150,223 | 910,849 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $22,356,130 | 605,529 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $16,826,123 | 505,289 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $12,535,510 | 483,064 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $2,989,363 | 133,038 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $745,383 | 31,411 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $570,698 | 23,789 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $499,338 | 22,853 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $82,039 | 4,293 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $168,401 | 8,676 | Shares | Defined | 2023-05-04 | |
| 2022-09-30 | $68,725 | 4,383 | Shares | Defined | 2022-12-01 | |
| No filing history on record for this holder in this stock. | ||||||